Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-027086

Chief Executive Officer sold 14,683 shares at $246.26 ($3,615,821)

  • Chief Executive Officer gave up 8,781.14 shares (to pay taxes)
  • Chief Executive Officer acquired 14,683 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-07 Exercise or conversion : show line 1 in the form 10b5-1 +14,683 $84.98 $1,247,761 478,937 D
2024-11-07 Sale : show line 2 in the form 10b5-1 −14,683 $246.26 $3,615,821 464,254 D
2024-11-11 Shares withheld for taxes : show line 3 in the form 10b5-1 −3,101.38 $252.38 $782,725 461,152 D
2024-11-11 Shares withheld for taxes : show line 4 in the form 10b5-1 −2,226.86 $252.38 $562,016 458,925 D
2024-11-11 Shares withheld for taxes : show line 5 in the form 10b5-1 −3,452.9 $252.38 $871,443 455,472 D
Open-market sales · 14,683 sh · avg $246.26 · $3,615,821

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-07 Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options −14,683 0 D
Loading xslF345X05/form4.xml…